These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15168808)

  • 21. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I; Vandewalle P; Cheikhrouhou F; Makni F; Krichen MS; Sendid B; Standaert-Vitse A; Ayadi A; Poulain D
    Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health.
    Sendid B; Cornu M; Cordier C; Bouckaert J; Colombel JF; Poulain D
    Autoimmun Rev; 2024 Feb; 23(2):103486. PubMed ID: 38040100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
    Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
    Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
    Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR
    Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
    Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
    Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
    Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients.
    Shafran I; Piromalli C; Decker JW; Sandoval J; Naser SA; El-Zaatari FA
    Dig Dis Sci; 2002 Sep; 47(9):2079-81. PubMed ID: 12353858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactivity of yeast antigens in human colon and peripheral leukocytes.
    Oshitani N; Hato F; Suzuki K; Sawa Y; Matsumoto T; Maeda K; Higuchi K; Kitagawa S; Arakawa T
    J Pathol; 2003 Mar; 199(3):361-7. PubMed ID: 12579538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
    Kim YS; Kim YH; Kim WH; Kim JS; Park YS; Yang SK; Ye BD; Jang BI; Jung SA; Jeen YT; Cheon JH; Choi YS; Choi JH; Kim BJ; Choi CH; Han DS
    Clin Chim Acta; 2011 Aug; 412(17-18):1527-32. PubMed ID: 21575618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
    Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.
    Van Kemseke C; Belaïche J; Steeman C; Louis E
    Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.
    Lindberg E; Magnusson KE; Tysk C; Järnerot G
    Gut; 1992 Jul; 33(7):909-13. PubMed ID: 1644330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
    Sendid B; Dotan N; Nseir S; Savaux C; Vandewalle P; Standaert A; Zerimech F; Guery BP; Dukler A; Colombel JF; Poulain D
    Clin Vaccine Immunol; 2008 Dec; 15(12):1868-77. PubMed ID: 18971303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans colonization and ASCA in familial Crohn's disease.
    Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
    Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.